Apruritic scabies presenting on interleukin-31 blockade with nemolizumab: a case report
Clinical and Experimental Dermatology · 21.07.2026
DOI: 10.1093/ced/llag309 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical and Experimental Dermatology, online erschienen am 21.07.2026. Verfasst von Bindi Gaglani und 4 weiteren Autor:innen. Beteiligte Einrichtung: St. John's Institute of Dermatology, London, UK. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Nemolizumab, a humanized IgG2 monoclonal antibody that inhibits interleukin (IL)-31 signalling by binding to the IL-31 receptor alpha (IL-31 RA) and a first-in-class IL-31 RA antagonist, has proven effective at reducing pruritus and objective skin signs in atopic dermatitis and nodular prurigo. However, by suppressing itch, nemolizumab may also delay the presentation of pruritic skin conditions such as scabies, potentially complicating the diagnosis. This case highlights a patient who developed a late presentation of scabies while on long-term nemolizumab therapy. The delayed pruritic response to scabies, likely due to the suppression of itch by nemolizumab, underscores the need for thorough dermatological evaluation.
Autor:innen und Institutionen
- St. John's Institute of Dermatology, London, UK.
- Guy's and St. Thomas' Hospitals NHS Trust, London, UK.
Zitieren
APA
Gaglani, B., Agius, E., Smith, C. H., Woolf, R., & Pink, A. (2026). Apruritic scabies presenting on interleukin-31 blockade with nemolizumab: a case report. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llag309
Vancouver
Gaglani B, Agius E, Smith CH, Woolf R, Pink A. Apruritic scabies presenting on interleukin-31 blockade with nemolizumab: a case report. Clinical and Experimental Dermatology. 2026. doi:10.1093/ced/llag309
BibTeX
@article{Gaglani2026,
author = {Gaglani, Bindi and Agius, Elaine and Smith, Catherine H and Woolf, Richard and Pink, Andrew},
title = {Apruritic scabies presenting on interleukin-31 blockade with nemolizumab: a case report},
journal = {Clinical and Experimental Dermatology},
year = {2026},
doi = {10.1093/ced/llag309}
}
EUVIMED